Terminalia bellirica stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro

British Journal of Nutrition

Volumn 103, Issue 2, 2010, Pages 212-217

  Kasabri, Violet ^a,b   Flatt, Peter R ^a   Abdel Wahab, Yasser H A ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Diabetes; Insulin; Terminalia bellirica

Indexed keywords

ANTIDIABETIC AGENT; CALCIUM ION; DIAZOXIDE; GLIBENCLAMIDE; GLUCOSE; INSULIN; PLANT EXTRACT; STARCH; TERMINALIA BELLIRICA EXTRACT; TOLBUTAMIDE; UNCLASSIFIED DRUG; VERAPAMIL; CALCIUM;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EXTRACELLULAR CALCIUM; GLUCOSE TRANSPORT; IN VITRO STUDY; INDIA; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PLANT; PROTEIN GLYCOSYLATION; TERMINALIA BELLIRICA; ANIMAL; CELL LINE; DIGESTION; DRUG EFFECT; FRUIT; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; RAT; SECRETION; TERMINALIA;

TERMINALIA BELLIRICA;

ANIMALS; CALCIUM; CELL LINE; DIAZOXIDE; DIGESTION; FRUIT; INSULIN; ISLETS OF LANGERHANS; PLANT EXTRACTS; RATS; STARCH; TERMINALIA; VERAPAMIL;

EID: 75549085296     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991577     Document Type: Article

References (25)

1. International Diabetes Federation (2006) Diabetes Atlas, 3rd ed. http://www.eatlas.idf.org/
2. World Health Organization (1980) Expert Committee on Diabetes Mellitus. WHO Technical Report Series no. 646. Geneva: WHO.
3. Day C (1990) Hypoglycaemic compounds from plants. In New Anti-Diabetic Drugs, pp. 267-278 [CJ Bailey and PR Flatt, editors]. London: Smith-Gordon.
4. Weragoda PB (1980) Some questions about the future of traditional medicine in developing countries. J Ethnopharmacol 2, 193-194.
5. Gray AM & Flatt PR (1997) Nature's own pharmacy: the diabetes perspective. Proc Nutr Soc 56, 507-517.
6. Hannan JMA, Marenah L, Ali L, et al. (2006) Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic b-cells. J Endocrinol 189, 127-136.
7. Hannan JMA, Ali L, Rokeya B, et al. (2007) Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr 97, 514-521.
8. Duke JA, Bogenschutz-Godwin MJ, Ducelliar J, et al. (2002) Handbook of Medicinal Herbs, 2nd ed., pp. 70-71. Boca Raton, FL: CRC Press.
9. Nandy AK, Podder G, Sabu NP, et al. (1989) Triterpenoids and their glucosides from Terminalia bellerica. Phytochemistry 28, 2769-2772.
10. Khan A-U & Gilani AH (2008) Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect. J Food Drug Anal 16, 6-14.
11. Sabu MC & Kuttan R (2002) Antidiabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 2, 155-160.
12. Chopra R, Nayar S & Chopra I (1956) Glossary of Indian Medicinal Plants, pp. 241-242. New Delhi: Council of Scientific and Industrial Research.
13. Singh AK, Raghubanshi AS & Singh JS (2002) Medical ethnobotany of the tribals of Sonaghati of Sonbhadra district, Uttar Pradesh, India. J Ethnopharmacol 81, 31-41.
14. Sharma HK, Chhangte L & Dolui AK (2001) Traditional medicinal plants in Mizoram, India. Fitoterapia 72, 146-161.
15. McClenaghan NH, Barnett CR, Ah-Sing E, et al. (1996) Characterisation of a novel glucose responsive insulin secreting cell line, BRIN BD11, produced by electrofusion. Diabetes 45, 1132-1140.
16. Flatt PR & Bailey CJ (1980) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/\+) mice. Diabetologia 20, 573-577.
17. Mathews JN, Flatt PR & Abdel-Wahab YH (2006) Asparagus adscendens (Shweta musali) stimulates insulin secretion, insulin action and inhibits starch digestion. Br J Nutr 95, 576-581.
18. Frost SC & Lane MD (1985) Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260, 2646-2652.
19. O'Harte FP, Hørjup P & Flatt PR (1996) Identification of the site of glycation of human insulin. Peptides 17, 1323-1330.
20. Dunn CJ & Peters DH (1995) Metformin: a review of its pharmacological properties and therapeutic use in NIDDM. Drugs 49, 721-749.
21. Yoshikuni Y (1998) Inhibition of intestinal a-glucosidase activity in postprandial hyperglycaemia by moraline and its n-alkyl derivatives. Agric Biol Chem 52, 121-128.
22. Kurihara H, Fukami H, Kusumoto A, et al. (2003) Hypoglycae-mic action of Cyclocarya paliurus (Batal) Iljinskaja in normal and diabetic mice. Biosci Biotechnol Biochem 67, 877-880.
23. Kawabata J, Mizuhatak K, Sato E, et al. (2003) 6-Hydroxyflavo-noids as a-glucosidase inhibitors from marjoram (Origanum majorana) leaves. Biosci Biotechnol Biochem 67, 445-447.
24. Abdel-Wahab YHA, Barnett CR, O'Harte FPM, et al. (1996) Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45, 1489-1496.
25. Hunter SJ, Boyd AC, O'Harte FP, et al. (2003) Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans. Diabetes 52, 492-498.